Infinity Pharma (INFI) Misses Q1 EPS by 1c

Infinity Pharma (NASDAQ: INFI) reported Q1 EPS of ($0.14), $0.01 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $652 thousand versus the consensus estimate of $340 thousand.

For earnings history and earnings-related data on Infinity Pharma (INFI) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• Pan American Silver (PAAS) Misses Q2 EPS by 19c